Irina Heid
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Journal: Nature medicine
Published: January 29, 2026
Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 18, 2025
3D virtual biopsy of in vivo pH and metabolism using PRESS and semi-LASER MRS of hyperpolarized 13C nuclei.
Journal: Magnetic resonance in medicine
Published: December 16, 2024
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Journal: Nature medicine
Published: May 30, 2024
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.
Journal: Nature biomedical engineering
Published: March 01, 2023
Spectrally selective bSSFP using off-resonant RF excitations permits high spatiotemporal resolution 3D metabolic imaging of hyperpolarized [1-13 C]Pyruvate-to-[1-13 C]lactate conversion.
Journal: Magnetic resonance in medicine
Published: November 23, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma.
Journal: Cancer & metabolism
Published: June 13, 2022
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 28, 2022
Last Updated: 09/26/2026